[Treatment of meningitis caused by Bacteroides fragilis with injections of ornidazole]. 1977

M Cadoz, and B Deborne, and C Lafaix, and O Langlois-Zantain, and A Dublanchet

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008581 Meningitis Inflammation of the coverings of the brain and/or spinal cord, which consist of the PIA MATER; ARACHNOID; and DURA MATER. Infections (viral, bacterial, and fungal) are the most common causes of this condition, but subarachnoid hemorrhage (HEMORRHAGES, SUBARACHNOID), chemical irritation (chemical MENINGITIS), granulomatous conditions, neoplastic conditions (CARCINOMATOUS MENINGITIS), and other inflammatory conditions may produce this syndrome. (From Joynt, Clinical Neurology, 1994, Ch24, p6) Pachymeningitis,Meningitides,Pachymeningitides
D009593 Nitroimidazoles IMIDAZOLES having a nitro moiety. Nitroimidazole
D009950 Ornidazole A nitroimidazole antiprotozoal agent used in ameba and trichomonas infections. It is partially plasma-bound and also has radiation-sensitizing action. Ro 7-0207,Ro-70207,Ro7-0207,Tiberal,Ro 7 0207,Ro 70207,Ro7 0207,Ro70207
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001441 Bacteroides fragilis Gram-negative bacteria occurring in the lower intestinal tracts of man and other animals. It is the most common species of anaerobic bacteria isolated from human soft tissue infections.
D001442 Bacteroides Infections Infections with bacteria of the genus BACTEROIDES. Infections, Bacteroides,Bacteroides Infection,Infection, Bacteroides

Related Publications

M Cadoz, and B Deborne, and C Lafaix, and O Langlois-Zantain, and A Dublanchet
August 1984, Canadian Medical Association journal,
M Cadoz, and B Deborne, and C Lafaix, and O Langlois-Zantain, and A Dublanchet
November 1989, Boletin medico del Hospital Infantil de Mexico,
M Cadoz, and B Deborne, and C Lafaix, and O Langlois-Zantain, and A Dublanchet
May 1980, Postgraduate medical journal,
M Cadoz, and B Deborne, and C Lafaix, and O Langlois-Zantain, and A Dublanchet
June 1994, Singapore medical journal,
M Cadoz, and B Deborne, and C Lafaix, and O Langlois-Zantain, and A Dublanchet
January 1987, Reviews of infectious diseases,
M Cadoz, and B Deborne, and C Lafaix, and O Langlois-Zantain, and A Dublanchet
June 1977, Lancet (London, England),
M Cadoz, and B Deborne, and C Lafaix, and O Langlois-Zantain, and A Dublanchet
February 1985, Journal of clinical microbiology,
M Cadoz, and B Deborne, and C Lafaix, and O Langlois-Zantain, and A Dublanchet
January 2012, Internal medicine (Tokyo, Japan),
M Cadoz, and B Deborne, and C Lafaix, and O Langlois-Zantain, and A Dublanchet
January 2004, Journal of postgraduate medicine,
M Cadoz, and B Deborne, and C Lafaix, and O Langlois-Zantain, and A Dublanchet
March 1976, La Nouvelle presse medicale,
Copied contents to your clipboard!